Mechanisms for cellular cholesterol transport: Defects and human disease

Physiological Reviews

Volumn 86, Issue 4, 2006, Pages 1237-1261

  Ikonen, Elina ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

3BETA (2 DIETHYLAMINOETHOXY)ANDROST 5 EN 17 ONE; ACID LIPASE; AMPHOTERICIN B; BILE ACID; CAVEOLIN 1; CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE; CHOLESTEROL ACYLTRANSFERASE INHIBITOR; EZETIMIBE; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOPROTEIN; NEUROSTEROID; NYSTATIN; OXYSTEROL; SPHINGOLIPID; STEROID HORMONE; STEROL DERIVATIVE; TRIPARANOL;

ATHEROSCLEROSIS; BILE ACID SYNTHESIS; CELL TRANSPORT; CEREBROTENDINOUS XANTHOMATOSIS; CHOLESTEROL ESTER STORAGE DISEASE; CHOLESTEROL ESTERIFICATION; CHOLESTEROL INTAKE; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CHOLESTEROL TRANSPORT; CONGENITAL ADRENAL HYPERPLASIA; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; DRUG MECHANISM; ENDOSOME; ENZYME REPLACEMENT; FAMILIAL HYPERCHOLESTEROLEMIA; HOMEOSTASIS; HUMAN; HYDROLYSIS; HYPERLIPIDEMIA; INTRACELLULAR SPACE; LIPID ABSORPTION; LIPID RAFT; MONOGENIC DISORDER; NIEMANN PICK DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SITOSTEROLEMIA; SMITH LEMLI OPITZ SYNDROME; STEROIDOGENESIS; TANGIER DISEASE; TRANSCRIPTION REGULATION; WOLMAN DISEASE;

ANIMALS; BIOLOGICAL TRANSPORT; CARDIOVASCULAR DISEASES; CELL MEMBRANE; CHOLESTEROL; CYTOPLASMIC VESICLES; HUMANS; HYPERCHOLESTEROLEMIA; INTRACELLULAR MEMBRANES; STEROIDS;

EID: 33749464296     PISSN: 00319333     EISSN: 15221210     Source Type: Journal    
DOI: 10.1152/physrev.00022.2005     Document Type: Review

References (278)

1. Abad-Rodriguez J, Ledesma MD, Craessaerts K, Perga S, Medina M, Delacourte A, Dingwall C, De Strooper B, and Dotti CG. Neuronal membrane cholesterol loss enhances amyloid peptide generation. J Cell Biol 167: 953-960, 2004.
2. Abifadel M, Varret M, Rabes JP, Allard D, Ouguerram K, Devillers M, Cruaud C, Benjannet S, Wickham L, Erlich D, Derre A, Villeger L, Farnier M, Beucler I, Bruckert E, Chambaz J, Chanu B, Lecerf JM, Luc G, Moulin P, Weissenbach J, Prat A, Krempf M, Junien C, Seidah NG, and Boileau C. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet 34: 154-156, 2003.
3. Abildayeva K, Jansen PJ, Hirsch-Reinshagen V, Bloks VW, Bakker AH, Ramaekers FC, De Vente J, Groen AK, Wellington CL, Kuipers F, and Mulder M. 24(S)-Hydroxycholesterol participates in a liver X receptor-controlled pathway in astrocytes that regulates Apolipoprotein E-mediated cholesterol efflux. J Biol Chem. In press.
4. Aiello RJ, Brees D, and Francone OL. ABCA1-deficient mice: insights into the role of monocyte lipid efflux in HDL formation and inflammation. Arterioscler Thromb Vasc Biol 23: 972-980, 2003.
5. Alpy F and Tomasetto C. Give lipids a START: the StAR-related lipid transfer (START) domain in mammals. J Cell Sci 118: 2791-2801, 2005.
6. Altmann SW, Davis HR Jr, Zhu LJ, Yao X, Hoos LM, Tetzloff G, Iyer SP, Maguire M, Golovko A, Zeng M, Wang L, Murgolo N, and Graziano MP. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science 303: 1201-1204, 2004.
7. Anderson RA, Byrum RS, Coates PM, and Sando GN. Mutations at the lysosomal acid cholesteryl ester hydrolase gene locus in Wolman disease. Proc Natl Acad Sci USA 91: 2718-2722, 1994.
8. Arca M, Zuliani G, Wilund K, Campagna F, Fellin R, Bertolini S, Calandra S, Ricci G, Glorioso N, Maioli M, Pintus P, Carru C, Cossu F, Cohen J, and Hobbs HH. Autosomal recessive hypercholesterolaemia in Sardinia, Italy, and mutations in ARH: a clinical and molecular genetic analysis. Lancet 359: 841-847, 2002.
9. Aridor M, Fish KN, Bannykh S, Weissman J, Roberts TH, Lippincott-Schwartz J, and Balch WE. The Sar1 GTPase coordinates biosynthetic cargo selection with endoplasmic reticulum export site assembly. J Cell Biol 152: 213-229, 2001.
10. Aslanidis C, Ries S, Fehringer P, Buchler C, Klima H, and Schmitz G. Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity. Genomics 33: 85-93, 1996.
11. Assmann G and Seedorf U. Acid lipase deficiency: Wolman disease and cholesteryl ester storage disease. In: The Metabolic and Molecular Bases of Inherited Disease (6th ed.), edited by Scriver CR, Beaudet AL, Sly WS, and Valle D. New York: McGraw-Hill, 1995, p. 2563-2587.
12. Austen B, Christodoulou G, and Terry JE. Relation between cholesterol levels, statins and Alzheimer's disease in the human population. J Nutr Health Aging 6: 377-382, 2002.
13. Ballantyne CM, Houri J, Notarbartolo A, Melani L, Lipka LJ, Suresh R, Sun S, LeBeaut AP, Sager PT, and Veltri EP. Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial. Circulation 107: 2409-2415, 2003.
14. Baumann NA, Sullivan DP, Ohvo-Rekila H, Simonot C, Pottekat A, Klaassen Z, Beh CT, and Menon AK. Transport of newly synthesized sterol to the sterol-enriched plasma membrane occurs via nonvesicular equilibration. Biochemistry 44: 5816-5826, 2005.
15. Beaven SW and Tontonoz P. Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemia. Annu Rev Med 57: 313-329, 2006.
16. Berge KE, Tian H, Graf GA, Yu L, Grishin NV, Schultz J, Kwiterovich P, Shan B, Barnes R, and Hobbs HH. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 290: 1771-1775, 2000.
17. Berriot-Varoqueaux N, Aggerbeck LP, and Samson-Bouma M. Microsomal triglyceride transfer protein and abetalipoproteinemia. Ann Endocrinol 61: 125-129, 2000.
18. Bhattacharyya AK and Connor WE. Beta-sitosterolemia and xanthomatosis. A newly described lipid storage disease in two sisters. J Clin Invest 53: 1033-1043, 1974.
19. Bjorkhem I and Eggertsen G. Genes involved in initial steps of bile acid synthesis. Curr Opin Lipidol 12: 97-103, 2001.
20. Bodzioch M, Orso E, Klucken J, Langmann T, Bottcher A, Diederich W, Drobnik W, Barlage S, Buchler C, Porsch-Ozcurumez M, Kaminski WE, Hahmann HW, Oette K, Rothe G, Aslanidis C, Lackner KJ, and Schmitz G. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 22: 347-351, 1999.
21. Bose H, Lingappa VR, and Miller WL. Rapid regulation of steroidogenesis by mitochondrial protein import. Nature 417: 87-91, 2002.
22. Bose HS, Sugawara T, Strauss JF III, and Miller WL. The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. International Congenital Lipoid Adrenal Hyperplasia Consortium. N Engl J Med 335: 1870-1878, 1996.
23. Braun A, Trigatti BL, Post MJ, Sato K, Simons M, Edelberg JM, Rosenberg RD, Schrenzel M, and Krieger M. Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice. Circ Res 90: 270-276, 2002.
24. Brooks-Wilson A, Marcil M, Clee SM, Zhang LH, Roomp K, van Dam M, Yu L, Brewer C, Collins JA, Molhuizen HO, Loubser O, Ouelette BF, Fichter K, Ashbourne-Excoffon KJ, Sensen CW, Scherer S, Mott S, Denis M, Martindale D, Frohlich J, Morgan K, Koop B, Pimstone S, Kastelein JJ, Genest J Jr, and Hayden MR. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 22: 336-345, 1999.
25. Brundert M, Ewert A, Heeren J, Behrendt B, Ramakrishnan R, Greten H, Merkel M, and Rinninger F. Scavenger receptor class B type I mediates the selective uptake of high-density lipoprotein-associated cholesteryl ester by the liver in mice. Arterioscler Thromb Vasc Biol 25: 143-148, 2005.
26. Buhman KK, Accad M, Novak S, Choi RS, Wong JS, Hamilton RL, Turley S, and Farese RV Jr. Resistance to diet-induced hypercholesterolemia and gallstone formation in ACAT2-deficient mice. Nat Med 6: 1341-1347, 2000.
27. Burton BK and Reed SP. Acid lipase cross-reacting material in Wolman disease and cholesterol ester storage disease. Am J Hum Genet 33: 203-208, 1981.
28. Cali JJ, Hsieh CL, Francke U, and Russell DW. Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis. J Biol Chem 266: 7779-7783, 1991.
29. Caron KM, Soo SC, Wetsel WC, Stocco DM, Clark BJ, and Parker KL. Targeted disruption of the mouse gene encoding steroidogenic acute regulatory protein provides insights into congenital lipoid adrenal hyperplasia. Proc Natl Acad Sci USA 94: 11540-11545, 1997.
30. Carstea ED, Morris JA, Coleman KG, Loftus SK, Zhang D, Cummings C, Gu J, Rosenfeld MA, Pavan WJ, Krizman DB, Nagle J, Polymeropoulos MH, Sturley SL, Ioannou YA, Higgins ME, Comly M, Cooney A, Brown A, Kaneski CR, Blanchette-Mackie EJ, Dwyer NK, Neufeld EB, Chang TY, Liscum L, Strauss JF, 3rd Ohno K, Zeigler M, Carmi R, Sokol J, Markie D, O'Neill RR, van Diggelen OP, Elleder M, Patterson MC, Brady RO, Vanier MT, Pentchev PG, and Tagle DA. Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science 277: 228-231, 1997.
31. Chang BH, Liao W, Li L, Nakamuta M, Mack D, and Chan L. Liver-specific inactivation of the abetalipoproteinemia gene completely abrogates very low density lipoprotein/low density lipoprotein production in a viable conditional knockout mouse. J Biol Chem 274: 6051-6055, 1999.
32. Chang TY, Chang CC, and Cheng D. Acyl-coenzyme A:cholesterol acyltransferase. Annu Rev Biochem 66: 613-638, 1997.
33. Chang TY, Chang CC, Lin S, Yu C, Li BL, and Miyazaki A. Roles of acyl-coenzyme A:cholesterol acyltransferase-1 and -2. Curr Opin Lipidol 12: 289-296, 2001.
34. Chang TY, Reid PC, Sugii S, Ohgami N, Cruz JC, and Chang CC. Niemann-Pick type C disease and intracellular cholesterol trafficking. J Biol Chem 280: 20917-20920, 2005.
35. Chen M, Kakutani M, Minami M, Kataoka H, Kume N, Narumiya S, Kita T, Masaki T, and Sawamura T. Increased expression of lectin-like oxidized low density lipoprotein receptor-1 in initial atherosclerotic lesions of Watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb Vasc Biol 20: 1107-1115, 2000.
36. Chen M, Masaki T, and Sawamura T. LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis. Pharmacol Ther 95: 89-100, 2002.
37. Chen M, Nagase M, Fujita T, Narumiya S, Masaki T, and Sawamura T. Diabetes enhances lectin-like oxidized LDL receptor-1 (LOX-1) expression in the vascular endothelium: possible role of LOX-1 ligand and AGE. Biochem Biophys Res Commun 287: 962-968, 2001.
38. Chen W, Wang N, and Tall AR. A PEST deletion mutant of ABCA1 shows impaired internalization and defective cholesterol efflux from late endosomes. J Biol Chem 280: 29277-29281, 2005.
39. Choi HY, Karten B, Chan T, Vance JE, Greer WL, Heidenreich RA, Garver WS, and Francis GA. Impaired ABCA1-dependent lipid efflux and hypoalphalipoproteinemia in human Niemann-Pick type C disease. J Biol Chem 278: 32569-32577, 2003.
40. Cohen AW, Hnasko R, Schubert W, and Lisanti MP. Role of caveolae and caveolins in health and disease. Physiol Rev 84: 1341-1379, 2004.
41. Cohen JC, Kiss RS, Pertsemlidis A, Marcel YL, McPherson R, and Hobbs HH. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 305: 869-872, 2004.
42. Cohen JC, Pertsemlidis A, Fahmi S, Esmail S, Vega GL, Grundy SM, and Hobbs HH. Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels. Proc Natl Acad Sci USA 103: 1810-1815, 2006.
43. Compagnone NA and Mellon SH. Neurosteroids: biosynthesis and function of these novel neuromodulators. Front Neuroendocrinol 21: 1-56, 2000.
44. Cooper MK, Wassif CA, Krakowiak PA, Taipale J, Gong R, Kelley RI, Porter FD, and Beachy PA. A defective response to Hedgehog signaling in disorders of cholesterol biosynthesis. Nat Genet 33: 508-513, 2003.
45. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, and Pericak-Vance MA. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923, 1993.
46. Davies JP and Ioannou YA. Topological analysis of Niemann-Pick C1 protein reveals that the membrane orientation of the putative sterol-sensing domain is identical to those of 3-hydroxy-3-methylglutaryl-CoA reductase and sterol regulatory element binding protein cleavage-activating protein. J Biol Chem 275: 24367-24374, 2000.
47. Davies JP, Levy B, and Ioannou YA. Evidence for a Niemannpick C (NPC) gene family: identification and characterization of NPC1L1. Genomics 65: 137-145, 2000.
48. Davies JP, Scott C, Oishi K, Liapis A, and Ioannou YA. Inactivation of NPC1L1 causes multiple lipid transport defects and protects against diet-induced hypercholesterolemia. J Biol Chem 280: 12710-12720, 2005.
49. Davis HR Jr, Zhu LJ, Hoos LM, Tetzloff G, Maguire M, Liu J, Yao X, Iyer SP, Lam MH, Lund EG, Detmers PA, Graziano MP, and Altmann SW. Niemann-Pick C1 Like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis. J Biol Chem 279: 33586-33592, 2004.
50. De Winther MP, van Dijk KW, Havekes LM, and Hofker MH. Macrophage scavenger receptor class A: a multifunctional receptor in atherosclerosis. Arterioscler Thromb Vasc Biol 20: 290-297, 2000.
51. Dietschy JM and Turley SD. Control of cholesterol turnover in the mouse. J Biol Chem 277: 3801-3804, 2002.
52. Du H, Duanmu M, Witte D, and Grabowski GA. Targeted disruption of the mouse lysosomal acid lipase gene: long-term survival with massive cholesteryl ester and triglyceride storage. Hum Mol Genet 7: 1347-1354, 1998.
53. Du H, Heur M, Duanmu M, Grabowski GA, Hui DY, Witte DP, and Mishra J. Lysosomal acid lipase-deficient mice: depletion of white and brown fat, severe hepatosplenomegaly, and shortened life span. J Lipid Res 42: 489-500, 2001.
54. Du H, Levine M, Ganesa C, Witte DP, Cole ES, and Grabowski GA. The role of mannosylated enzyme and the mannose receptor in enzyme replacement therapy. Am J Hum Genet 77: 1061-1074, 2005.
55. Dubrac S, Lear SR, Ananthanarayanan M, Balasubramaniyan N, Bollineni J, Shefer S, Hyogo H, Cohen DE, Blanche PJ, Krauss RM, Batta AK, Salen G, Suchy FJ, Maeda N, and Erickson SK. Role of CYP27A in cholesterol and bile acid metabolism. J Lipid Res 46: 76-85, 2005.
56. Dujovne CA, Ettinger MP, McNeer JF, Lipka LJ, LeBeaut AP, Suresh R, Yang B, and Veltri EP. Efficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemia. Am J Cardiol 90: 1092-1097, 2002.
57. Durrington PN. Familial hypercholesterolemia. In: Hyperlipidemia: Diagnosis and Management, edited by Durrington PN. Oxford, UK: Butterworth-Heinemann, 1995, p. 108-140.
58. Eck MV, Pennings M, Hoekstra M, Out R, and Van Berkel TJ. Scavenger receptor BI and ATP-binding cassette transporter A1 in reverse cholesterol transport and atherosclerosis. Curr Opin Lipidol 16: 307-315, 2005.
59. Eskelinen EL, Schmidt CK, Neu S, Willenborg M, Fuertes G, Salvador N, Tanaka Y, Lullmann-Rauch R, Hartmann D, Heeren J, von Figura K, Knecht E, and Saftig P. Disturbed cholesterol traffic but normal proteolytic function in LAMP-1/LAMP-2 double-deficient fibroblasts. Mol Biol Cell 15: 3132-3145, 2004.
60. Evans M, Roberts A, Davies S, and Rees A. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments. Drugs 64: 1181-1196, 2004.
61. Fassbender K, Simons M, Bergmann C, Stroick M, Lutjohann D, Keller P, Runz H, Kuhl S, Bertsch T, von Bergmann K, Hennerici M, Beyreuther K, and Hartmann T. Simvastatin strongly reduces levels of Alzheimer's disease beta-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc Natl Acad Sci USA 98: 5856-5861, 2001.
62. Fazio S, Major AS, Swift LL, Gleaves LA, Accad M, Linton MF, and Farese RV Jr. Increased atherosclerosis in LDL receptor-null mice lacking ACAT1 in macrophages. J Clin Invest 107: 163-171, 2001.
63. Febbraio M, Podrez EA, Smith JD, Hajjar DP, Hazen SL, Hoff HF, Sharma K, and Silverstein RL. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J Clin Invest 105: 1049-1056, 2000.
64. Fielding CJ and Fielding PE. Molecular physiology of reverse cholesterol transport. J Lipid Res 36: 211-228, 1995.
65. Fonarow GC and Watson KE. Effective strategies for long-term statin use. Am J Cardiol 92: 27i-34i, 2003.
66. Frank PG, Lee H, Park DS, Tandon NN, Scherer PE, and Lisanti MP. Genetic ablation of caveolin-1 confers protection against atherosclerosis. Arterioscler Thromb Vasc Biol 24: 98-105, 2004.
67. Friedland N, Liou HL, Lobel P, and Stock AM. Structure of a cholesterol-binding protein deficient in Niemann-Pick type C2 disease. Proc Natl Acad Sci USA 100: 2512-2517, 2003.
68. Frikke-Schmidt R, Nordestgaard BG, Jensen GB, and Tybjaerg-Hansen A. Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population. J Clin Invest 114: 1343-1353, 2004.
69. Frikke-Schmidt R, Nordestgaard BG, Schnohr P, Steffensen R, and Tybjaerg-Hansen A. Mutation in ABCA1 predicted risk of ischemic heart disease in the Copenhagen City Heart Study Population. J Am Coll Cardiol 46: 1516-1520, 2005.
70. Frolov A, Zielinski SE, Crowley JR, Dudley-Rucker N, Schaffer JE, and Ory DS. NPC1 and NPC2 regulate cellular cholesterol homeostasis through generation of low density lipoprotein cholesterol-derived oxysterols. J Biol Chem 278: 25517-25525, 2003.
71. Garcia CK, Wilund K, Arca M, Zuliani G, Fellin R, Maioli M, Calandra S, Bertolini S, Cossu F, Grishin N, Barnes R, Cohen JC, and Hobbs HH. Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein. Science 292: 1394-1398, 2001.
72. Garcia-Calvo M, Lisnock J, Bull HG, Hawes BE, Burnett DA, Braun MP, Crona JH, Davis HR Jr, Dean DC, Detmers PA, Graziano MP, Hughes M, Macintyre DE, Ogawa A, O'Neill K A, Iyer SP, Shevell DE, Smith MM, Tang YS, Makarewicz AM, Ujjainwalla F, Altmann SW, Chapman KT, and Thornberry NA. The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1). Proc Natl Acad Sci USA 102: 8132-8137, 2005.
73. Gelissen IC, Harris M, Rye KA, Quinn C, Brown AJ, Kockx M, Cartland S, Packianathan M, Kritharides L, and Jessup W. ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I. Arterioscler Thromb Vasc Biol 26: 534-540, 2006.
74. Ghosh S. Cholesteryl ester hydrolase in human monocyte/macrophage: cloning, sequencing, and expression of full-length cDNA. Physiol Gen 2: 1-8, 2000.
75. Ghosh S, Mallonee DH, Hylemon PB, and Grogan WM. Molecular cloning and expression of rat hepatic neutral cholesteryl ester hydrolase. Biochim Biophys Acta 1259: 305-312, 1995.
76. Ghosh S, Natarajan R, Pandak WM, Hylemon PB, and Grogan WM. Regulation of hepatic neutral cholesteryl ester hydrolase by hormones and changes in cholesterol flux. Am J Physiol Gastrointest Liver Physiol 274: G662-G668, 1998.
77. Gofflot F, Hars C, Illien F, Chevy F, Wolf C, Picard JJ, and Roux C. Molecular mechanisms underlying limb anomalies associated with cholesterol deficiency during gestation: implications of Hedgehog signaling. Hum Mol Genet 12: 1187-1198, 2003.
78. Goldstein JL, DeBose-Boyd RA, and Brown MS. Protein sensors for membrane sterols. Cell 124: 35-46, 2006.
79. Goldstein JL, Ho YK, Basu SK, and Brown MS. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA 76: 333-337, 1979.
80. Goldstein JL, Hobbs HH, and Brown MS. Familial hypercholesterolemia. In: The Metabolic and Molecular Bases of Inherited Disease (6th ed.), edited by Scriver CR, Beaudet AL, Sly WS, and Valle D. New York: McGraw-Hill, 1995, p. 1981-2030.
81. Graf GA, Li WP, Gerard RD, Gelissen I, White A, Cohen JC, and Hobbs HH. Coexpression of ATP-binding cassette proteins ABCG5 and ABCG8 permits their transport to the apical surface. J Clin Invest 110: 659-669, 2002.
82. Graf GA, Yu L, Li WP, Gerard R, Tuma PL, Cohen JC, and Hobbs HH. ABCG5 and ABCG8 are obligate heterodimers for protein trafficking and biliary cholesterol excretion. J Biol Chem 278: 48275-48282, 2003.
83. Griffin LD, Gong W, Verot L, and Mellon SH. Niemann-Pick type C disease involves disrupted neurosteroidogenesis and responds to allopregnanolone. Nat Med 10: 704-711, 2004.
84. Grimm MO, Grimm HS, Patzold AJ, Zinser EG, Halonen R, Duering M, Tschape JA, De Strooper B, Muller U, Shen J, and Hartmann T. Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin. Nat Cell Biol 7: 1118-1123, 2005.
85. Grundy SM. Absorption and metabolism of dietary cholesterol. Annu Rev Nutr 3: 71-96, 1983.
86. 3H]cholesterol efflux to high and low density lipoproteins is dependent on lipoprotein binding to the receptor. J Biol Chem 275: 29993-30001, 2000.
87. Gylling H and Miettinen TA. Inheritance of cholesterol metabolism of probands with high or low cholesterol absorption. J Lipid Res 43: 1472-1476, 2002.
88. Gylling H, Radhakrishnan R, and Miettinen TA. Reduction of serum cholesterol in postmenopausal women with previous myocardial infarction and cholesterol malabsorption induced by dietary sitostanol ester margarine: women and dietary sitostanol. Circulation 96: 4226-4231, 1997.
89. Harder CJ, Vassiliou G, McBride HM, and McPherson R. Hepatic SR-BI-mediated cholesteryl ester selective uptake occurs with unaltered efficiency in the absence of cellular energy. J Lipid Res 47: 492-503, 2006.
90. Hasegawa T, Zhao L, Caron KM, Majdic G, Suzuki T, Shizawa S, Sasano H, and Parker KL. Developmental roles of the steroidogenic acute regulatory protein (StAR) as revealed by StAR knockout mice. Mol Endocrinol 14: 1462-1471, 2000.
91. Heath KE, Gahan M, Whittall RA, and Humphries SE. Low-density lipoprotein receptor gene (LDLR) world-wide website in familial hypercholesterolaemia: update, new features and mutation analysis. Atherosclerosis 154: 243-246, 2001.
92. Heino S, Lusa S, Somerharju P, Ehnholm C, Olkkonen VM, and Ikonen E. Dissecting the role of the Golgi complex and lipid rafts in biosynthetic transport of cholesterol to the cell surface. Proc Natl Acad Sci USA 97: 8375-8380, 2000.
93. Herman GE. Disorders of cholesterol biosynthesis: prototypic metabolic malformation syndromes. Hum Mol Genet 12: R75-R88, 2003.
94. Hogenboom S, Tuyp JJ, Espeel M, Koster J, Wanders RJ, and Waterham HR. Mevalonate kinase is a cytosolic enzyme in humans. J Cell Sci 117: 631-639, 2004.
95. Holick MF. Defects in the synthesis and metabolism of vitamin D. Exp Clin Endocrinol Diabetes 103: 219-227, 1995.
96. Holtta-Vuori M, Alpy F, Tanhuanpaa K, Jokitalo E, Mutka AL, and Ikonen E. MLN64 is involved in actin-mediated dynamics of late endocytic organelles. Mol Biol Cell 16: 3873-3886, 2005.
97. Holtta-Vuori M and Ikonen E. Endosomal cholesterol traffic: vesicular and non-vesicular mechanisms meet. Biochem Soc Trans 34: 392-394, 2006.
98. Holtta-Vuori M, Maatta J, Ullrich O, Kuismanen E, and Ikonen E. Mobilization of late-endosomal cholesterol is inhibited by Rab guanine nucleotide dissociation inhibitor. Curr Biol 10: 95-98, 2000.
99. Honda A, Salen G, Matsuzaki Y, Batta AK, Xu G, Leitersdorf E, Tint GS, Erickson SK, Tanaka N, and Shefer S. Differences in hepatic levels of intermediates in bile acid biosynthesis between Cyp27(-/-) mice and CTX. J Lipid Res 42: 291-300, 2001.
100. Houten SM, Wanders RJ, and Waterham HR. Biochemical and genetic aspects of mevalonate kinase and its deficiency. Biochim Biophys Acta 1529: 19-32, 2000.
101. Hui DY and Howles PN. Molecular mechanisms of cholesterol absorption and transport in the intestine. Semin Cell Dev Biol 16: 183-192, 2005.
102. Hussain MM, Maxfield FR, Mas-Oliva J, Tabas I, Ji ZS, Innerarity TL, and Mahley RW. Clearance of chylomicron remnants by the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. J Biol Chem 266: 13936-13940, 1991.
103. Ikonen E, Heino S, and Lusa S. Caveolins and membrane cholesterol. Biochem Soc Trans 32: 121-123, 2004.
104. Ikonen E and Holtta-Vuori M. Cellular pathology of Niemann-Pick type C disease. Semin Cell Dev Biol 15: 445-454, 2004.
105. Ingham PW. Hedgehog signaling: a tale of two lipids. Science 294: 1879-1881, 2001.
106. Ji Y, Jian B, Wang N, Sun Y, Moya ML, Phillips MC, Rothblat GH, Swaney JB, and Tall AR. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J Biol Chem 272: 20982-20985, 1997.
107. Jick H, Zornberg GL, Jick SS, Seshadri S, and Drachman DA. Statins and the risk of dementia. Lancet 356: 1627-1631, 2000.
108. Jones B, Jones EL, Bonney SA, Patel HN, Mensenkamp AR, Eichenbaum-Voline S, Rudling M, Myrdal U, Annesi G, Naik S, Meadows N, Quattrone A, Islam SA, Naoumova RP, Angelin B, Infante R, Levy E, Roy CC, Freemont PS, Scott J, and Shoulders CC. Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders. Nat Genet 34: 29-31, 2003.
109. Joyce C, Freeman L, Brewer HB Jr, and Santamarina-Fojo S. Study of ABCA1 function in transgenic mice. Arterioscler Thromb Vasc Biol 23: 965-971, 2003.
110. Karten B, Campenot RB, Vance DE, and Vance JE. Expression of ABCG1, but not ABCA1, correlates with cholesterol release by cerebellar astroglia. J Biol Chem 281: 4049-4057, 2006.
111. Kastelein J. What future for combination therapies? Int J Clin Pract Suppl 134: 45-50, 2003.
112. Katzov H, Chalmers K, Palmgren J, Andreasen N, Johansson B, Cairns NJ, Gatz M, Wilcock GK, Love S, Pedersen NL, Brookes AJ, Blennow K, Kehoe PG, and Prince JA. Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism. Hum Mutat 23: 358-367, 2004.
113. Khelef N, Soe TT, Quehenberger O, Beatini N, Tabas I, and Maxfield FR. Enrichment of acyl coenzyme A:cholesterol O-acyltransferase near trans-Golgi network and endocytic recycling compartment. Arterioscler Thromb Vasc Biol 20: 1769-1776, 2000.
114. Klett EL and Patel S. Genetic defenses against noncholesterol sterols. Curr Opin Lipidol 14: 341-345, 2003.
115. Ko DC, Binkley J, Sidow A, and Scott MP. The integrity of a cholesterol-binding pocket in Niemann-Pick C2 protein is necessary to control lysosome cholesterol levels. Proc Natl Acad Sci USA 100: 2518-2525, 2003.
116. Kobayashi T, Beuchat MH, Lindsay M, Frias S, Palmiter RD, Sakuraba H, Parton RG, and Gruenberg J. Late endosomal membranes rich in lysobisphosphatidic acid regulate cholesterol transport. Nat Cell Biol 1: 113-118, 1999.
117. Kosters A, Jirsa M, and Groen AK. Genetic background of cholesterol gallstone disease. Biochim Biophys Acta 1637: 1-19, 2003.
118. Kovacs WJ and Krisans S. Cholesterol biosynthesis and regulation: role of peroxisomes. Adv Exp Med Biol 544: 315-327, 2003.
119. Krieger M. Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems. J Clin Invest 108: 793-797, 2001.
120. Kruit JK, Plosch T, Havinga R, Boverhof R, Groot PH, Groen AK, and Kuipers F. Increased fecal neutral sterol loss upon liver X receptor activation is independent of biliary sterol secretion in mice. Gastroenterology 128: 147-156, 2005.
121. Kunjathoor VV, Febbraio M, Podrez EA, Moore KJ, Andersson L, Koehn S, Rhee JS, Silverstein R, Hoff HF, and Freeman MW. Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J Biol Chem 277: 49982-49988, 2002.
122. Lachmann RH, te Vruchte D, Lloyd-Evans E, Reinkensmeier G, Sillence DJ, Fernandez-Guillen L, Dwek RA, Butters TD, Cox TM, and Platt FM. Treatment with miglustat reverses the lipid-trafficking defect in Niemann-Pick disease type C. Neurobiol Dis 16: 654-658, 2004.
123. Lange Y, Echevarria F, and Steck TL. Movement of zymosterol, a precursor of cholesterol, among three membranes in human fibroblasts. J Biol Chem 266: 21439-21443, 1991.
124. Lange Y, Ye J, Rigney M, and Steck T. Cholesterol movement in Niemann-Pick type C cells and in cells treated with amphiphiles. J Biol Chem 275: 17468-17475, 2000.
125. Lee MH, Lu K, Hazard S, Yu H, Shulenin S, Hidaka H, Kojima H, Allikmets R, Sakuma N, Pegoraro R, Srivastava AK, Salen G, Dean M, and Patel SB. Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat Genet 27: 79-83, 2001.
126. Li D and Mehta JL. Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells. Circulation 101: 2889-2895, 2000.
127. Liao JK and Laufs U. Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 45: 89-118, 2005.
128. Lin D, Sugawara T, Strauss JF III, Clark BJ, Stocco DM, Saenger P, Rogol A, and Miller WL. Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science 267: 1828-1831, 1995.
129. Lin S, Lu X, Chang CC, and Chang TY. Human acyl-coenzyme A:cholesterol acyltransferase expressed in Chinese hamster ovary cells: membrane topology and active site location. Mol Biol Cell 14: 2447-2460, 2003.
130. Linton MF, Hasty AH, Babaev VR, and Fazio S. Hepatic apo E expression is required for remnant lipoprotein clearance in the absence of the low density lipoprotein receptor. J Clin Invest 101: 1726-1736, 1998.
131. Liscum L. Niemann-Pick type C mutations cause lipid traffic jam. Traffic 1: 218-225, 2000.
132. Liscum L and Faust JR. Low density lipoprotein (LDL)-mediated suppression of cholesterol synthesis and LDL uptake is defective in Niemann-Pick type C fibroblasts. J Biol Chem 262: 17002-17008, 1987.
133. Llaverias G, Laguna JC, and Alegret M. Pharmacology of the ACAT inhibitor avasimibe (CI-1011). Cardiovasc Drug Rev 21: 33-50, 2003.
134. London E and Brown DA. Insolubility of lipids in Triton X-100: physical origin and relationship to sphingolipid/cholesterol membrane domains (rafts). Biochim Biophys Acta 1508: 182-195, 2000.
135. Lund EG, Kerr TA, Sakai J, Li WP, and Russell DW. cDNA cloning of mouse and human cholesterol 25-hydroxylases, polytopic membrane proteins that synthesize a potent oxysterol regulator of lipid metabolism. J Biol Chem 273: 34316-34327, 1998.
136. Lusa S, Blom TS, Eskelinen EL, Kuismanen E, Mansson JE, Simons K, and Ikonen E. Depletion of rafts in late endocytic membranes is controlled by NPC1-dependent recycling of cholesterol to the plasma membrane. J Cell Sci 114: 1893-1900, 2001.
137. Lusa S, Heino S, and Ikonen E. Differential mobilization of newly synthesized cholesterol and biosynthetic sterol precursors from cells. J Biol Chem 278: 19844-19851, 2003.
138. Lutjohann D, Bjorkhem I, Beil UF, and von Bergmann K. Sterol absorption and sterol balance in phytosterolemia evaluated by deuterium-labeled sterols: effect of sitostanol treatment. J Lipid Res 36: 1763-1773, 1995.
139. Mace S, Cousin E, Ricard S, Genin E, Spanakis E, Lafargue-Soubigou C, Genin B, Fournel R, Roche S, Haussy G, Massey F, Soubigou S, Brefort G, Benoit P, Brice A, Campion D, Hollis M, Pradier L, Benavides J, and Deleuze JF. ABCA2 is a strong genetic risk factor for early-onset Alzheimer's disease. Neurobiol Dis 18: 119-125, 2005.
140. Malathi K, Higaki K, Tinkelenberg AH, Balderes DA, Almanzar-Paramio D, Wilcox LJ, Erdeniz N, Redican F, Padamsee M, Liu Y, Khan S, Alcantara F, Carstea ED, Morris JA, and Sturley SL. Mutagenesis of the putative sterol-sensing domain of yeast Niemann Pick C-related protein reveals a primordial role in subcellular sphingolipid distribution. J Cell Biol 164: 547-556, 2004.
141. Marais AD, Firth JC, Bateman ME, Byrnes P, Martens C, and Mountney J. Atorvastatin: an effective lipid-modifying agent in familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 17: 1527-1531, 1997.
142. Marais AD, Naoumova RP, Firth JC, Penny C, Neuwirth CK, and Thompson GR. Decreased production of low density lipoprotein by atorvastatin after apheresis in homozygous familial hypercholesterolemia. J Lipid Res 38: 2071-2078, 1997.
143. Maric J, Kiss RS, Franklin V, and Marcel YL. Intracellular lipidation of newly synthesized apolipoprotein A-I in primary murine hepatocytes. J Biol Chem 280: 39942-39949, 2005.
144. Martin S and Parton RG. Caveolin, cholesterol, and lipid bodies. Semin Cell Dev Biol 16: 163-174, 2005.
145. Matter K, Whitney JA, Yamamoto EM, and Mellman I. Common signals control low density lipoprotein receptor sorting in endosomes and the Golgi complex of MDCK cells. Cell 74: 1053-1064, 1993.
146. Mauch DH, Nagler K, Schumacher S, Goritz C, Muller EC, Otto A, and Pfrieger FW. CNS synaptogenesis promoted by glia-derived cholesterol. Science 294: 1354-1357, 2001.
147. Maxfield FR and Tabas I. Role of cholesterol and lipid organization in disease. Nature 438: 612-621, 2005.
148. Maxfield FR and Wustner D. Intracellular cholesterol transport. J Clin Invest 110: 891-898, 2002.
149. Maxwell KN and Breslow JL. Proprotein convertase subtilisin kexin 9: the third locus implicated in autosomal dominant hypercholesterolemia. Curr Opin Lipidol 16: 167-172, 2005.
150. Meiner VL, Cases S, Myers HM, Sande ER, Bellosta S, Schambelan M, Pitas RE, McGuire J, Herz J, and Farese RV Jr. Disruption of the acyl-CoA:cholesterol acyltransferase gene in mice: evidence suggesting multiple cholesterol esterification enzymes in mammals. Proc Natl Acad Sci USA 93: 14041-14046, 1996.
151. Meir KS and Leitersdorf E. Atherosclerosis in the apolipoprotein-E- deficient mouse: a decade of progress. Arterioscler Thromb Vasc Biol 24: 1006-1014, 2004.
152. Menkes JH, Schimschock JR, and Swanson PD. Cerebrotendinous xanthomatosis. The storage of cholestanol within the nervous system. Arch Neurol 19: 47-53, 1968.
153. Millard EE, Gale SE, Dudley N, Zhang J, Schaffer JE, and Ory DS. The sterol-sensing domain of the Niemann-Pick C1 (NPC1) protein regulates trafficking of low density lipoprotein cholesterol. J Biol Chem 280: 28581-28590, 2005.
154. Miller WL and Strauss JF III. Molecular pathology and mechanism of action of the steroidogenic acute regulatory protein, StAR. J Steroid Biochem Mol Biol 69: 131-141, 1999.
155. Mishra SK, Keyel PA, Hawryluk MJ, Agostinelli NR, Watkins SC, and Traub
156. Miwa K, Inazu A, Kobayashi J, Higashikata T, Nohara A, Kawashiri M, Katsuda S, Takata M, Koizumi J, and Mabuchi H. ATP-binding cassette transporter G8 M429V polymorphism as a novel genetic marker of higher cholesterol absorption in hypercholesterolaemic Japanese subjects. Clin Sci 109: 183-188, 2005.
157. Miyake JH, Duong-Polk XT, Taylor JM, Du EZ, Castellani LW, Lusis AJ, and Davis RA. Transgenic expression of cholesterol-7-alpha-hydroxylase prevents atherosclerosis in C57BL/6J mice. Arterioscler Thromb Vasc Biol 22: 121-126, 2002.
158. Moghadasian MH. Cerebrotendinous xanthomatosis: clinical course, genotypes and metabolic backgrounds. Clin Invest Med 27: 42-50, 2004.
159. Morris SM and Cooper JA. Disabled-2 colocalizes with the LDLR in clathrin-coated pits and interacts with AP-2. Traffic 2: 111-123, 2001.
160. Mulligan JD, Flowers MT, Tebon A, Bitgood JJ, Wellington C, Hayden MR, and Attie AD. ABCA1 is essential for efficient basolateral cholesterol efflux during the absorption of dietary cholesterol in chickens. J Biol Chem 278: 13356-13366, 2003.
161. Murata M, Peranen J, Schreiner R, Wieland F, Kurzchalia TV, and Simons K. VIP21/caveolin is a cholesterol-binding protein. Proc Natl Acad Sci USA 92: 10339-10343, 1995.
162. Naik SU, Wang X, Da Silva JS, Jaye M, Macphee CH, Reilly MP, Billheimer JT, Rothblat GH, and Rader DJ. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo. Circulation 113: 90-97, 2006.
163. Naureckiene S, Sleat DE, Lackland H, Fensom A, Vanier MT, Wattiaux R, Jadot M, and Lobel P. Identification of HE1 as the second gene of Niemann-Pick C disease. Science 290: 2298-2301, 2000.
164. Neufeld EB, Stonik JA, Demosky SJ Jr, Knapper CL, Combs CA, Cooney A, Comly M, Dwyer N, Blanchette-Mackie J, Remaley AT, Santamarina-Fojo S, and Brewer HB Jr. The ABCA1 transporter modulates late endocytic trafficking: insights from the correction of the genetic defect in Tangier disease. J Biol Chem 279: 15571-15578, 2004.
165. Nicholls SJ, Rye KA, and Barter PJ. High-density lipoproteins as therapeutic targets. Curr Opin Lipidol 16: 345-349, 2005.
166. Ohgami N, Ko DC, Thomas M, Scott MP, Chang CC, and Chang TY. Binding between the Niemann-Pick C1 protein and a photoactivatable cholesterol analog requires a functional sterol-sensing domain. Proc Natl Acad Sci USA 101: 12473-12478, 2004.
167. Ohmori R, Momiyama Y, Nagano M, Taniguchi H, Egashira T, Yonemura A, Nakamura H, Kondo K, and Ohsuzu F. An oxidized low-density lipoprotein receptor gene variant is inversely associated with the severity of coronary artery disease. Clin Cardiol 27: 641-644, 2004.
168. Okuda KI. Liver mitochondrial P450 involved in cholesterol catabolism and vitamin D activation. J Lipid Res 35: 361-372, 1994.
169. Olkkonen VM and Lehto M. Oxysterols and oxysterol binding proteins: role in lipid metabolism and atherosclerosis. Ann Med 36: 562-572, 2004.
170. Olkkonen VM and Levine TP. Oxysterol binding proteins: in more than one place at one time? Biochem Cell Biol 82: 87-98, 2004.
171. Out R, Hoekstra M, Spijkers JA, Kruijt JK, van Eck M, Bos IS, Twisk J, and Van Berkel TJ. Scavenger receptor class B type I is solely responsible for the selective uptake of cholesteryl esters from HDL by the liver and the adrenals in mice. J Lipid Res 45: 2088-2095, 2004.
172. Pagler TA, Rhode S, Neuhofer A, Laggner H, Strobl W, Hinterndorfer C, Volf I, Pavelka M, Eckhardt ER, van der Westhuyzen DR, Schutz GJ, and Stangl H. SR-BI mediated HDL endocytosis leads to HDL resecretion facilitating cholesterol efflux. J Biol Chem. In press.
173. Papadopoulos V. In search of the function of the peripheral-type benzodiazepine receptor. Endocr Res 30: 677-684, 2004.
174. Parton RG, Hanzal-Bayer M, and Hancock JF. Biogenesis of caveolae: a structural model for caveolin-induced domain formation. J Cell Sci 119: 787-796, 2006.
175. Patel SB. Ezetimibe: a novel cholesterol-lowering agent that highlights novel physiologic pathways. Curr Cardiol Rep 6: 439-442, 2004.
176. Pentchev PG, Comly ME, Kruth HS, Vanier MT, Wenger DA, Patel S, and Brady RO. A defect in cholesterol esterification in Niemann-Pick disease (type C) patients. Proc Natl Acad Sci USA 82: 8247-8251, 1985.
177. Piedrahita JA, Zhang SH, Hagaman JR, Oliver PM, and Maeda N. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci USA 89: 4471-4475, 1992.
178. Plump AS, Smith JD, Hayek T, Aalto-Setala K, Walsh A, Verstuyft JG, Rubin EM, and Breslow JL. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71: 343-353, 1992.
179. Porter FD. Human malformation syndromes due to inborn errors of cholesterol synthesis. Curr Opin Pediatr 15: 607-613, 2003.
180. Pramfalk C, Davis MA, Eriksson M, Rudel LL, and Parini P. Control of ACAT2 liver expression by HNF1. J Lipid Res 46: 1868-1876, 2005.
181. Prattes S, Horl G, Hammer A, Blaschitz A, Graier WF, Sattler W, Zechner R, and Steyrer E. Intracellular distribution and mobilization of unesterified cholesterol in adipocytes: triglyceride droplets are surrounded by cholesterol-rich ER-like surface layer structures. J Cell Sci 113: 2977-2989, 2000.
182. Puglielli L, Konopka G, Pack-Chung E, Ingano LA, Berezovska O, Hyman BT, Chang TY, Tanzi RE, and Kovacs DM. Acyl-coenzyme A: cholesterol acyltransferase modulates the generation of the amyloid beta-peptide. Nat Cell Biol 3: 905-912, 2001.
183. Pullinger CR, Eng C, Salen G, Shefer S, Batta AK, Erickson SK, Verhagen A, Rivera CR, Mulvihill SJ, Malloy MJ, and Kane JP. Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype. J Clin Invest 110: 109-117, 2002.
184. Raabe M, Flynn LM, Zlot CH, Wong JS, Veniant MM, Hamilton RL, and Young SG. Knockout of the abetalipoproteinemia gene in mice: reduced lipoprotein secretion in heterozygotes and embryonic lethality in homozygotes. Proc Natl Acad Sci USA 95: 8686-8691, 1998.
185. Raabe M, Veniant MM, Sullivan MA, Zlot CH, Bjorkegren J, Nielsen LB, Wong JS, Hamilton RL, and Young SG. Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice. J Clin Invest 103: 1287-1298, 1999.
186. Radhakrishnan A, Sun LP, Kwon HJ, Brown MS, and Goldstein JL. Direct binding of cholesterol to the purified membrane region of SCAP: mechanism for a sterol-sensing domain. Mol Cell 15: 259-268, 2004.
187. Ragozin S, Niemeier A, Laatsch A, Loeffler B, Merkel M, Beisiegel U, and Heeren J. Knockdown of hepatic ABCA1 by RNA interference decreases plasma HDL cholesterol levels and influences postprandial lipemia in mice. Arterioscler Thromb Vasc Biol 25: 1433-1438, 2005.
188. Razani B, Combs TP, Wang XB, Frank PG, Park DS, Russell RG, Li M, Tang B, Jelicks LA, Scherer PE, and Lisanti MP. Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities. J Biol Chem 277: 8635-8647, 2002.
189. Reinhart MP, Billheimer JT, Faust JR, and Gaylor JL. Subcellular localization of the enzymes of cholesterol biosynthesis and metabolism in rat liver. J Biol Chem 262: 9649-9655, 1987.
190. Repa JJ, Dietschy JM, and Turley SD. Inhibition of cholesterol absorption by SCH 58053 in the mouse is not mediated via changes in the expression of mRNA for ABCA1, ABCG5, or ABCG8 in the enterocyte. J Lipid Res 43: 1864-1874, 2002.
191. Rigotti A, Trigatti BL, Penman M, Rayburn H, Herz J, and Krieger M. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc Natl Acad Sci USA 94: 12610-12615, 1997.
192. Rodriguez-Agudo D, Ren S, Hylemon PB, Redford K, Natarajan R, Del Castillo A, Gil G, and Pandak WM. Human StarD5, a cytosolic StAR-related lipid binding protein. J Lipid Res 46: 1615-1623, 2005.
193. Rosen H, Reshef A, Maeda N, Lippoldt A, Shpizen S, Triger L, Eggertsen G, Bjorkhem I, and Leitersdorf E. Markedly reduced bile acid synthesis but maintained levels of cholesterol and vitamin D metabolites in mice with disrupted sterol 27-hydroxylase gene. J Biol Chem 273: 14805-14812, 1998.
194. Rothberg KG, Heuser JE, Donzell WC, Ying YS, Glenney JR, and Anderson RG. Caveolin, a protein component of caveolae membrane coats. Cell 68: 673-682, 1992.
195. Runz H, Rietdorf J, Tomic I, de Bernard M, Beyreuther K, Pepperkok R, and Hartmann T. Inhibition of intracellular cholesterol transport alters presenilin localization and amyloid precursor protein processing in neuronal cells. J Neurosci 22: 1679-1689, 2002.
196. Rust S, Rosier M, Funke H, Real J, Amoura Z, Piette JC, Deleuze JF, Brewer HB, Duverger N, Denefle P, and Assmann G. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet 22: 352-355, 1999.
197. Sakashita N, Miyazaki A, Takeya M, Horiuchi S, Chang CC, Chang TY, and Takahashi K. Localization of human acyl-coenzyme A: cholesterol acyltransferase-1 (ACAT-1) in macrophages and in various tissues. Am J Pathol 156: 227-236, 2000.
198. Salen G, Horak I, Rothkopf M, Cohen JL, Speck J, Tint GS, Shore V, Dayal B, Chen T, and Shefer S. Lethal atherosclerosis associated with abnormal plasma and tissue sterol composition in sitosterolemia with xanthomatosis. J Lipid Res 26: 1126-1133, 1985.
199. Salen G, Shore V, Tint GS, Forte T, Shefer S, Horak I, Horak E, Dayal B, Nguyen L, Batta AK, Lindgren FT, and Kwiterovich PO. Increased sitosterol absorption, decreased removal, and expanded body pools compensate for reduced cholesterol synthesis in sitosterolemia with xanthomatosis. J Lipid Res 30: 1319-1330, 1989.
200. Salen G, von Bergmann K, Lutjohann D, Kwiterovich P, Kane J, Patel SB, Musliner T, Stein P, and Musser B. Ezetimibe effectively reduces plasma plant sterols in patients with sitosterolemia. Circulation 109: 966-971, 2004.
201. Sawamura T, Kume N, Aoyama T, Moriwaki H, Hoshikawa H, Aiba Y, Tanaka T, Miwa S, Katsura Y, Kita T, and Masaki T. An endothelial receptor for oxidized low-density lipoprotein. Nature 386: 73-77, 1997.
202. Schekman R and Orci L. Coat proteins and vesicle budding. Science 271: 1526-1533, 1996.
203. Schmitz G, Robenek H, Lohmann U, and Assmann G. Interaction of high density lipoproteins with cholesteryl ester-laden macrophages: biochemical and morphological characterization of cell surface receptor binding, endocytosis and resecretion of high density lipoproteins by macrophages. EMBO J 4: 613-622, 1985.
204. Schonfeld G. Familial hypobetalipoproteinemia: a review. J Lipid Res 44: 878-883, 2003.
205. Schwarz M, Lund EG, and Russell DW. Two 7 alpha-hydroxylase enzymes in bile acid biosynthesis. Curr Opin Lipidol 9: 113-118, 1998.
206. Seidah NG, Benjannet S, Wickham L, Marcinkiewicz J, Jasmin SB, Stifani S, Basak A, Prat A, and Chretien M. The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation. Proc Natl Acad Sci USA 100: 928-933, 2003.
207. Serfaty-Lacrosniere C, Civeira F, Lanzberg A, Isaia P, Berg J, Janus ED, Smith MP Jr, Pritchard PH, Frohlich J, Lees RS, Barnard GF, Ordovas JM, and Schaefer EJ. Homozygous Tangier disease and cardiovascular disease. Atherosclerosis 107: 85-98, 1994.
208. Sever N, Yang T, Brown MS, Goldstein JL, and DeBose-Boyd RA. Accelerated degradation of HMG CoA reductase mediated by binding of insig-1 to its sterol-sensing domain. Mol Cell 11: 25-33, 2003.
209. Shima M, Tanae A, Miki K, Katsumata N, Matsumoto S, Nakajima S, Harada T, Shinagawa T, Tanaka T, and Okada S. Mechanism for the development of ovarian cysts in patients with congenital lipoid adrenal hyperplasia. Eur J Endocrinol 142: 274-279, 2000.
210. Shioji K, Mannami T, Kokubo Y, Inamoto N, Takagi S, Goto Y, Nonogi H, and Iwai N. Genetic variants in PCSK9 affect the cholesterol level in Japanese. J Hum Genet 49: 109-114, 2004.
211. Shoulders CC, Stephens DJ, and Jones B. The intracellular transport of chylomicrons requires the small GTPase, Sar1b. Curr Opin Lipidol 15: 191-197, 2004.
212. Silver DL, Wang N, Xiao X, and Tall AR. High density lipoprotein (HDL) particle uptake mediated by scavenger receptor class B type 1 results in selective sorting of HDL cholesterol from protein and polarized cholesterol secretion. J Biol Chem 276: 25287-25293, 2001.
213. Simons K and Ehehalt R. Cholesterol, lipid rafts, and disease. J Clin Invest 110: 597-603, 2002.
214. Simons K and Gruenberg J. Jamming the endosomal system: lipid rafts and lysosomal storage diseases. Trends Cell Biol 10: 459-462, 2000.
215. Simons K and Ikonen E. Functional rafts in cell membranes. Nature 387: 569-572, 1997.
216. Simons K and Ikonen E. How cells handle cholesterol. Science 290: 1721-1726, 2000.
217. Simons K and Vaz WL. Model systems, lipid rafts, and cell membranes. Annu Rev Biophys Biomol Struct 33: 269-295, 2004.
218. Skrede S, Bjorkhem I, Kvittingen EA, Buchmann MS, Lie SO, East C, and Grundy S. Demonstration of 26-hydroxylation of C27-steroids in human skin fibroblasts, and a deficiency of this activity in cerebrotendinous xanthomatosis. J Clin Invest 78: 729-735, 1986.
219. Slack J. Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states. Lancet 2: 1380-1382, 1969.
220. Sleat DE, Wiseman JA, El-Banna M, Price SM, Verot L, Shen MM, Tint GS, Vanier MT, Walkley SU, and Lobel P. Genetic evidence for nonredundant functional cooperativity between NPC1 and NPC2 in lipid transport. Proc Natl Acad Sci USA 101: 5886-5891, 2004.
221. Soccio RE and Breslow JL. Intracellular cholesterol transport. Arterioscler Thromb Vasc Biol 24: 1150-1160, 2004.
222. Soutar AK, Naoumova RP, and Traub LM. Genetics, clinical phenotype, and molecular cell biology of autosomal recessive hypercholesterolemia. Arterioscler Thromb Vasc Biol 23: 1963-1970, 2003.
223. Sparks DL, Connor DJ, Browne PJ, Lopez JE, and Sabbagh MN. HMG-CoA reductase inhibitors (statins) in the treatment of Alzheimer's disease and why it would be ill-advised to use one that crosses the blood-brain barrier. J Nutr Health Aging 6: 324-331, 2002.
224. Spencer TA, Li D, Russel JS, Collins JL, Bledsoe RK, Consler TG, Moore LB, Galardi CM, McKee DD, Moore JT, Watson MA, Parks DJ, Lambert MH, and Willson TM. Pharmacophore analysis of the nuclear oxysterol receptor LXRalpha. J Med Chem 44: 886-897, 2001.
225. Steck TL, Ye J, and Lange Y. Probing red cell membrane cholesterol movement with cyclodextrin. Biophys J 83: 2118-2125, 2002.
226. Stein O and Stein Y. Lipid transfer proteins (LTP) and atherosclerosis. Atherosclerosis 178: 217-230, 2005.
227. Stocco DM. Clinical disorders associated with abnormal cholesterol transport: mutations in the steroidogenic acute regulatory protein. Mol Cell Endocrinol 191: 19-25, 2002.
228. Stone NJ, Levy RI, Fredrickson DS, and Verter J. Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia. Circulation 49: 476-488, 1974.
229. Strauss JF III, Kishida T, Christenson LK, Fujimoto T, and Hiroi H. START domain proteins and the intracellular trafficking of cholesterol in steroidogenic cells. Mol Cell Endocrinol 202: 59-65, 2003.
230. Sturley SL, Patterson MC, Balch W, and Liscum L. The pathophysiology and mechanisms of NP-C disease. Biochim Biophys Acta 1685: 83-87, 2004.
231. Sugii S, Reid PC, Ohgami N, Du H, and Chang TY. Distinct endosomal compartments in early trafficking of low density lipoprotein-derived cholesterol. J Biol Chem 278: 27180-27189, 2003.
232. Swift LL, Zhu MY, Kakkad B, Jovanovska A, Neely MD, Valyi-Nagy K, Roberts RL, Ong DE, and Jerome WG. Subcellular localization of microsomal triglyceride transfer protein. J Lipid Res 44: 1841-1849, 2003.
233. Tabas I. Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. J Clin Invest 110: 905-911, 2002.
234. Tajima T, Fujieda K, Kouda N, Nakae J, and Miller WL. Heterozygous mutation in the cholesterol side chain cleavage enzyme (p450scc) gene in a patient with 46,XY sex reversal and adrenal insufficiency. J Clin Endocrinol Metab 86: 3820-3825, 2001.
235. Tanaka AR, Abe-Dohmae S, Ohnishi T, Aoki R, Morinaga G, Okuhira K, Ikeda Y, Kano F, Matsuo M, Kioka N, Amachi T, Murata M, Yokoyama S, and Ueda K. Effects of mutations of ABCA1 in the first extracellular domain on subcellular trafficking and ATP binding/hydrolysis. J Biol Chem 278: 8815-8819, 2003.
236. Tansey JT, Sztalryd C, Gruia-Gray J, Roush DL, Zee JV, Gavrilova O, Reitman ML, Deng CX, Li C, Kimmel AR, and Londos C. Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity. Proc Natl Acad Sci USA 98: 6494-6499, 2001.
237. Tatsuguchi M, Furutani M, Hinagata J, Tanaka T, Furutani Y, Imamura S, Kawana M, Masaki T, Kasanuki H, Sawamura T, and Matsuoka R. Oxidized LDL receptor gene (OLR1) is associated with the risk of myocardial infarction. Biochem Biophys Res Commun 303: 247-250, 2003.
238. Thiele C, Hannah MJ, Fahrenholz F, and Huttner WB. Cholesterol binds to synaptophysin and is required for biogenesis of synaptic vesicles. Nat Cell Biol 2: 42-49, 2000.
239. Thompson GR. A Handbook of Hyperlipidemia. London, UK: Current Science, 1994.
240. Timmins JM, Lee JY, Boudyguina E, Kluckman KD, Brunham LR, Mulya A, Gebre AK, Coutinho JM, Colvin PL, Smith TL, Hayden MR, Maeda N, and Parks JS. Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I. J Clin Invest 115: 1333-1342, 2005.
241. Tontonoz P and Mangelsdorf DJ. Liver X receptor signaling pathways in cardiovascular disease. Mol Endocrinol 17: 985-993, 2003.
242. Trigatti B, Rayburn H, Vinals M, Braun A, Miettinen H, Penman M, Hertz M, Schrenzel M, Amigo L, Rigotti A, and Krieger M. Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology. Proc Natl Acad Sci USA 96: 9322-9327, 1999.
243. Trigatti BL, Krieger M, and Rigotti A. Influence of the HDL receptor SR-BI on lipoprotein metabolism and atherosclerosis. Arterioscler Thromb Vasc Biol 23: 1732-1738, 2003.
244. Tsujishita Y and Hurley JH. Structure and lipid transport mechanism of a StAR-related domain. Nat Struct Biol 7: 408-414, 2000.
245. Turley SD and Dietschy JM. Sterol absorption by the small intestine. Curr Opin Lipidol 14: 233-240, 2003.
246. Underwood KW, Andemariam B, McWilliams GL, and Liscum L. Quantitative analysis of hydrophobic amine inhibition of intracellular cholesterol transport. J Lipid Res 37: 1556-1568, 1996.
247. Urbani L and Simoni RD. Cholesterol and vesicular stomatitis virus G protein take separate routes from the endoplasmic reticulum to the plasma membrane. J Biol Chem 265: 1919-1923, 1990.
248. Vainio S, Bykov I, Hermansson M, Jokitalo E, Somerharju P, and Ikonen E. Defective insulin receptor activation and altered lipid rafts in Niemann-Pick type C disease hepatocytes. Biochem J 391: 465-472, 2005.
249. Vainio S, Jansen M, Koivusalo M, Rog T, Karttunen M, Vattulainen I, and Ikonen E. Significance of sterol structural specificity. Desmosterol cannot replace cholesterol in lipid rafts. J Biol Chem 281: 348-355, 2006.
250. Vaisman BL, Lambert G, Amar M, Joyce C, Ito T, Shamburek RD, Cain WJ, Fruchart-Najib J, Neufeld ED, Remaley AT, Brewer HB Jr, and Santamarina-Fojo S. ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice. J Clin Invest 108: 303-309, 2001.
251. Valasek MA, Weng J, Shaul PW, Anderson RG, and Repa JJ. Caveolin-1 is not required for murine intestinal cholesterol transport. J Biol Chem 280: 28103-28109, 2005.
252. Vance JE, Hayashi H, and Karten B. Cholesterol homeostasis in neurons and glial cells. Semin Cell Dev Biol 16: 193-212, 2005.
253. Van Eck M, Bos IS, Hildebrand RB, Van Rij BT, and Van Berkel TJ. Dual role for scavenger receptor class B, type I on bone marrow-derived cells in atherosclerotic lesion development. Am J Pathol 165: 785-794, 2004.
254. Wang L, Fast DG, and Attie AD. The enzymatic and non-enzymatic roles of protein-disulfide isomerase in apolipoprotein B secretion. J Biol Chem 272: 27644-27651, 1997.
255. Wang N, Arai T, Ji Y, Rinninger F, and Tall AR. Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein ApoB, low density lipoprotein ApoB, and high density lipoprotein in transgenic mice. J Biol Chem 273: 32920-32926, 1998.
256. Wang N, Chen W, Linsel-Nitschke P, Martinez LO, Agerholm-Larsen B, Silver DL, and Tall AR. A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I. J Clin Invest 111: 99-107, 2003.
257. Wang N, Lan D, Chen W, Matsuura F, and Tall AR. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc Natl Acad Sci USA 101: 9774-9779, 2004.
258. Wang N, Silver DL, Costet P, and Tall AR. Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1. J Biol Chem 275: 33053-33058, 2000.
259. Wang N, Silver DL, Thiele C, and Tall AR. ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein. J Biol Chem 276: 23742-23747, 2001.
260. Wassif CA, Vied D, Tsokos M, Connor WE, Steiner RD, and Porter FD. Cholesterol storage defect in RSH/Smith-Lemli-Opitz syndrome fibroblasts. Mol Genet Metab 75: 325-334, 2002.
261. Wechsler A, Brafman A, Shafir M, Heverin M, Gottlieb H, Damari G, Gozlan-Kelner S, Spivak I, Moshkin O, Fridman E, Becker Y, Skaliter R, Einat P, Faerman A, Bjorkhem I, and Feinstein E. Generation of viable cholesterol-free mice. Science 302: 2087, 2003.
262. Welty FK, Lahoz C, Tucker KL, Ordovas JM, Wilson PW, and Schaefer EJ. Frequency of ApoB and ApoE gene mutations as causes of hypobetalipoproteinemia in the Framingham offspring population. Arterioscler Thromb Vasc Biol 18: 1745-1751, 1998.
263. Westman J, Kallin B, Bjorkhem I, Nilsson J, and Diczfalusy U. Sterol 27-hydroxylase- and apoAI/phospholipid-mediated efflux of cholesterol from cholesterol-laden macrophages: evidence for an inverse relation between the two mechanisms. Arterioscler Thromb Vasc Biol 18: 554-561, 1998.
264. Wetterau JR, Aggerbeck LP, Bouma ME, Eisenberg C, Munck A, Hermier M, Schmitz J, Gay G, Rader DJ, and Gregg RE. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science 258: 999-1001, 1992.
265. Willner EL, Tow B, Buhman KK, Wilson M, Sanan DA, Rudel LL, and Farese RV Jr. Deficiency of acyl CoA:cholesterol acyltransferase 2 prevents atherosclerosis in apolipoprotein E-deficient mice. Proc Natl Acad Sci USA 100: 1262-1267, 2003.
266. Wollmer MA, Streffer JR, Tsolaki M, Grimaldi LM, Lutjohann D, Thal D, von Bergmann K, Nitsch RM, Hock C, and Papassotiropoulos A. Genetic association of acyl-coenzyme A:cholesterol acyltransferase with cerebrospinal fluid cholesterol levels, brain amyloid load, and risk for Alzheimer's disease. Mol Psychiatry 8: 635-638, 2003.
267. Wolozin B, Kellman W, Ruosseau P, Celesia GG, and Siegel G. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol 57: 1439-1443, 2000.
268. Yancey PG, de la Llera-Moya M, Swarnakar S, Monzo P, Klein SM, Connelly MA, Johnson WJ, Williams DL, and Rothblat GH. High density lipoprotein phospholipid composition is a major determinant of the bi-directional flux and net movement of cellular free cholesterol mediated by scavenger receptor BI. J Biol Chem 275: 36596-36604, 2000.
269. Yeaman SJ. Hormone-sensitive lipase - new roles for an old enzyme. Biochem J 379: 11-22, 2004.
270. Yokoyama S. Assembly of high density lipoprotein by the ABCA1/apolipoprotein pathway. Curr Opin Lipidol 16: 269-279, 2005.
271. Yu KC and Cooper AD. Postprandial lipoproteins and atherosclerosis. Front Biosci 6: D332-D354, 2001.
272. Yu L, Bharadwaj S, Brown JM, Ma Y, Du W, Davis MA, Michaely P, Liu P, Willingham MC, and Rudel LL. Cholesterol-regulated translocation of NPC1L1 to the cell surface facilitates free cholesterol uptake. J Biol Chem 281: 6616-6624, 2006.
273. Yu L, Gupta S, Xu F, Liverman AD, Moschetta A, Mangelsdorf DJ, Repa JJ, Hobbs HH, and Cohen JC. Expression of ABCG5 and ABCG8 is required for regulation of biliary cholesterol secretion. J Biol Chem 280: 8742-8747, 2005.
274. Yu L, Hammer RE, Li-Hawkins J, Von Bergmann K, Lutjohann D, Cohen JC, and Hobbs HH. Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proc Natl Acad Sci USA 99: 16237-16242, 2002.
275. Yu L, Li-Hawkins J, Hammer RE, Berge KE, Horton JD, Cohen JC, and Hobbs HH. Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J Clin Invest 110: 671-680, 2002.
276. Zannis VI, Chroni A, and Krieger M. Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL. J Mol Med 84: 276-294, 2006.
277. Zhang J and Herscovitz H. Nascent lipidated apolipoprotein B is transported to the Golgi as an incompletely folded intermediate as probed by its association with network of endoplasmic reticulum molecular chaperones, GRP94, ERp72, BiP, calreticulin, and cyclophilin B. J Biol Chem 278: 7459-7468, 2003.
278. Zheng H, Kiss RS, Franklin V, Wang MD, Haidar B, and Marcel YL. ApoA-I lipidation in primary mouse hepatocytes. Separate controls for phospholipid and cholesterol transfers. J Biol Chem 280: 21612-21621, 2005.